201 related articles for article (PubMed ID: 16392031)
1. Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro.
Di Serio C; Cozzi A; Angeli I; Doria L; Micucci I; Pellerito S; Mirone P; Masotti G; Moroni F; Tarantini F
Cell Mol Neurobiol; 2005 Sep; 25(6):981-93. PubMed ID: 16392031
[TBL] [Abstract][Full Text] [Related]
2. Kynurenic Acid Prevents Cytoskeletal Disorganization Induced by Quinolinic Acid in Mixed Cultures of Rat Striatum.
Pierozan P; Biasibetti-Brendler H; Schmitz F; Ferreira F; Pessoa-Pureur R; Wyse ATS
Mol Neurobiol; 2018 Jun; 55(6):5111-5124. PubMed ID: 28840509
[TBL] [Abstract][Full Text] [Related]
3. Kynurenic acid attenuates NMDA-induced pial arteriolar dilation in newborn pigs.
Bari F; Nagy K; Guidetti P; Schwarcz R; Busija DW; Domoki F
Brain Res; 2006 Jan; 1069(1):39-46. PubMed ID: 16388784
[TBL] [Abstract][Full Text] [Related]
4. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
5. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
Carpenedo R; Meli E; Peruginelli F; Pellegrini-Giampietro DE; Moroni F
J Neurochem; 2002 Sep; 82(6):1465-71. PubMed ID: 12354294
[TBL] [Abstract][Full Text] [Related]
7. Kynurenic Acid Restores Nrf2 Levels and Prevents Quinolinic Acid-Induced Toxicity in Rat Striatal Slices.
Ferreira FS; Biasibetti-Brendler H; Pierozan P; Schmitz F; Bertó CG; Prezzi CA; Manfredini V; Wyse ATS
Mol Neurobiol; 2018 Nov; 55(11):8538-8549. PubMed ID: 29564809
[TBL] [Abstract][Full Text] [Related]
8. Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells.
Walczak K; Deneka-Hannemann S; Jarosz B; Zgrajka W; Stoma F; Trojanowski T; Turski WA; Rzeski W
Pharmacol Rep; 2014 Feb; 66(1):130-6. PubMed ID: 24905318
[TBL] [Abstract][Full Text] [Related]
9. Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Langner E; Lemieszek MK; Kwiecień JM; Rajtar G; Rzeski W; Turski WA
Neurochem Res; 2017 Mar; 42(3):838-845. PubMed ID: 27444613
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
[TBL] [Abstract][Full Text] [Related]
11. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
[TBL] [Abstract][Full Text] [Related]
12. Intrastriatal Quinolinic Acid Administration Impairs Redox Homeostasis and Induces Inflammatory Changes: Prevention by Kynurenic Acid.
Ferreira FS; Schmitz F; Marques EP; Siebert C; Wyse ATS
Neurotox Res; 2020 Jun; 38(1):50-58. PubMed ID: 32219734
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases.
Senggunprai L; Yoshinari K; Yamazoe Y
Biochem J; 2009 Aug; 422(3):455-62. PubMed ID: 19548878
[TBL] [Abstract][Full Text] [Related]
14. Kynurenic Acid Protects Against Reactive Glial-associated Reductions in the Complexity of Primary Cortical Neurons.
O'Reilly K; O'Farrell K; Midttun O; Rakovets Y; David-Bercholz J; Harkin A
J Neuroimmune Pharmacol; 2021 Sep; 16(3):679-692. PubMed ID: 33389453
[TBL] [Abstract][Full Text] [Related]
15. [Effects of antagonists of exciting amino acids on the neuro-destructive effect of quinolinic acid in vitro in comparison with their anticonvulsive action in situ].
Khaspekov LG; Lapin IP; Ryzhov IV; Viktorov IV
Biull Eksp Biol Med; 1989 Aug; 108(8):190-3. PubMed ID: 2529920
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of kynurenate neuroprotective potency and quinolinate excitotoxicity.
Obrenovitch TP; Urenjak J
Amino Acids; 2000; 19(1):299-309. PubMed ID: 11026501
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective potency of kynurenic acid against excitotoxicity.
Urenjak J; Obrenovitch TP
Neuroreport; 2000 Apr; 11(6):1341-4. PubMed ID: 10817618
[TBL] [Abstract][Full Text] [Related]
18. Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding.
Chess AC; Bucci DJ
Behav Brain Res; 2006 Jun; 170(2):326-32. PubMed ID: 16621049
[TBL] [Abstract][Full Text] [Related]
19. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels.
Mok MH; Fricker AC; Weil A; Kew JN
Neuropharmacology; 2009 Sep; 57(3):242-9. PubMed ID: 19523966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
